- Home
- AAOI vs APGE Comparison
AAOI vs APGE Comparison
Compare AAOI & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAOI
- APGE
- Stock Information
- Founded
- AAOI 1997
- APGE 2022
- Country
- AAOI United States
- APGE United States
- Employees
- AAOI N/A
- APGE N/A
- Industry
- AAOI Semiconductors
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AAOI Technology
- APGE Health Care
- Exchange
- AAOI Nasdaq
- APGE Nasdaq
- Market Cap
- AAOI 1.5B
- APGE 1.8B
- IPO Year
- AAOI 2013
- APGE 2023
- Fundamental
- Price
- AAOI $16.38
- APGE $39.72
- Analyst Decision
- AAOI Buy
- APGE Strong Buy
- Analyst Count
- AAOI 4
- APGE 4
- Target Price
- AAOI $32.25
- APGE $91.33
- AVG Volume (30 Days)
- AAOI 5.0M
- APGE 789.4K
- Earning Date
- AAOI 05-08-2025
- APGE 03-03-2025
- Dividend Yield
- AAOI N/A
- APGE N/A
- EPS Growth
- AAOI N/A
- APGE N/A
- EPS
- AAOI N/A
- APGE N/A
- Revenue
- AAOI $249,365,000.00
- APGE N/A
- Revenue This Year
- AAOI $113.96
- APGE N/A
- Revenue Next Year
- AAOI $48.75
- APGE $795.25
- P/E Ratio
- AAOI N/A
- APGE N/A
- Revenue Growth
- AAOI 14.57
- APGE N/A
- 52 Week Low
- AAOI $6.70
- APGE $29.10
- 52 Week High
- AAOI $44.50
- APGE $68.21
- Technical
- Relative Strength Index (RSI)
- AAOI 38.63
- APGE 55.27
- Support Level
- AAOI $19.65
- APGE $38.18
- Resistance Level
- AAOI $22.77
- APGE $41.07
- Average True Range (ATR)
- AAOI 1.93
- APGE 2.31
- MACD
- AAOI 0.18
- APGE 0.22
- Stochastic Oscillator
- AAOI 24.69
- APGE 63.77
About AAOI Applied Optoelectronics Inc.
Applied Optoelectronics Inc is a provider of fiber-optic networking products for the Internet data center, cable television, telecommunications and fiber-to-the-home end markets. The company focuses on designing and manufacturing a range of optical communication products from components, to subassemblies, and modules to complete turn-key equipment. Demand for Applied Optoelectronics is driven by bandwidth demand in end markets. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The company derives maximum revenue from Taiwan.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.